Drugs / Gag:267-274 peptide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01748747 | Oct 2012 → Dec 2014 | melanoma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gag:267-274 peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01748747 ↗ |
| Modality | Vaccine | “Gag:267-274 peptide vaccine” NCT01748747 ↗ |
| Route | Subcutaneous | “Gag:267-274 peptide vaccine emulsified in Montanide ISA 51 VG subcutaneously (SC)” NCT01748747 ↗ |